TDI-6118
TDI-6118 (Compound 5) is a potent inhibitor of EZH2. EZH2-IN-12 has the potential for the research of central nervous system malignancies[1].
Product Specifications
UNSPSC
12352005
Target
Histone Methyltransferase
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/tdi-6118.html
Purity
99.08
Solubility
DMSO : 25 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
CC1=CC(C)=C(C(N1C)=O)CN2CCC3=C(C=C(C(Cl)=C3C2=O)C4=C(ON=C4C)C)Cl
Molecular Formula
C23H23Cl2N3O3
Molecular Weight
460.35
References & Citations
[1]Liang R, et al. A Chemical Strategy toward Novel Brain-Penetrant EZH2 Inhibitors. ACS Med Chem Lett. 2022;13 (3) :377-387.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
EZH2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY402460 100 µg
Adracalin (AAAS) (NM_015665) Human Over-expression Lysate
Sign In for Pricing
View Details 
